The mitochondrial complex i inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism

The death of dopaminergic neurons induced by systemic administration of mitochondrial respiratory chain complex I inhibitors such as 1-methyl-4-phenylpyridinium (MPP(+); given as the prodrug 1-methyl-1,2,3,6-tetrahydropyridine) or the pesticide rotenone have raised the question as to whether this family of compounds are the cause of some forms of Parkinsonism. We have examined the neurotoxic potential of another complex I inhibitor, annonacin, the major acetogenin of Annona muricata (soursop), a tropical plant suspected to be the cause of an atypical form of Parkinson disease in the French West Indies (Guadeloupe). When added to mesencephalic cultures for 24 h, annonacin was much more potent than MPP(+) (effective concentration [EC(50)]=0.018 versus 1.9 microM) and as effective as rotenone (EC(50)=0.034 microM) in killing dopaminergic neurons. The uptake of [(3)H]-dopamine used as an index of dopaminergic cell function was similarly reduced. Toxic effects were seen at lower concentrations when the incubation time was extended by several days whereas withdrawal of the toxin after a short-term exposure (<6 h) arrested cell demise. Unlike MPP(+) but similar to rotenone, the acetogenin also reduced the survival of non-dopaminergic neurons. Neuronal cell death was not excitotoxic and occurred independently of free radical production. Raising the concentrations of either glucose or mannose in the presence of annonacin restored to a large extent intracellular ATP synthesis and prevented neuronal cell demise. Deoxyglucose reversed the effects of both glucose and mannose. Other hexoses such as galactose and fructose were not protective. Attempts to restore oxidative phosphorylation with lactate or pyruvate failed to provide protection to dopaminergic neurons whereas idoacetate, an inhibitor of glycolysis, inhibited the survival promoting effects of glucose and mannose indicating that these two hexoses acted independently of mitochondria by stimulating glycolysis. In conclusion, our study demonstrates that annonacin promotes dopaminergic neuronal death by impairment of energy production. It also underlines the need to address its possible role in the etiology of some atypical forms of Parkinsonism in Guadeloupe.

[1]  Alexis Elbaz,et al.  Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study , 1999, The Lancet.

[2]  M. Caron,et al.  Molecular characterization of the dopamine transporter. , 1993, Trends in pharmacological sciences.

[3]  Jean Féger,et al.  Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats , 2003, Journal of neurochemistry.

[4]  H. M. Geller,et al.  1‐Methyl‐4‐(2′‐Ethylphenyl)‐1,2,3,6‐Tetrahydropyridine‐ Induced Toxicity in PC12 Cells Is Enhanced by Preventing Glycolysis , 1992, Journal of neurochemistry.

[5]  K. O’Malley,et al.  The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation , 2000, The Journal of Biological Chemistry.

[6]  A. Storch,et al.  6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism , 2000, Journal of Neural Transmission.

[7]  Charles Duyckaerts,et al.  Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. , 2002, Brain : a journal of neurology.

[8]  S. Mandel,et al.  Genes and oxidative stress in parkinsonism: cDNA microarray studies. , 2003, Advances in neurology.

[9]  Todd B. Sherer,et al.  An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.

[10]  M. Esposti Inhibitors of NADH-ubiquinone reductase: an overview. , 1998 .

[11]  F. Hefti,et al.  Toxicity of 1‐Methyl‐4‐Phenylpyridinium for Rat Dopaminergic Neurons in Culture: Selectivity and Irreversibility , 1990, Journal of neurochemistry.

[12]  J. Tormo,et al.  Specific interactions of monotetrahydrofuranic annonaceous acetogenins as inhibitors of mitochondrial complex I. , 1999, Chemico-biological interactions.

[13]  Merle Ruberg,et al.  Toxicity of Annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe , 2002, Movement disorders : official journal of the Movement Disorder Society.

[14]  Y. Agid,et al.  The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures , 1992, Brain Research.

[15]  P. R. Gilmore,et al.  Glucose transport in primary cultured neurons , 1989, Journal of neuroscience research.

[16]  J. McLaughlin,et al.  Annonaceous acetogenins: recent progress. , 1999, Journal of natural products.

[17]  W. Staines,et al.  Immunohistochemical localization and quantification of glucose transporters in the mouse brain , 2002, Neuroscience.

[18]  A. Schapira,et al.  Mitochondrial involvement in Parkinson’s disease , 2002, Neurochemistry International.

[19]  A. Privat,et al.  Neuroprotection of cultured foetal rat hippocampal cells against glucose deprivation: are GABAergic neurons less vulnerable or more sensitive to TCP protection? , 1999, The European journal of neuroscience.

[20]  J. Langston,et al.  Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure , 1999, Annals of neurology.

[21]  S. Ochs,et al.  INHIBITION OF GLYCERALDEHYDE‐3‐PHOSPHATE DEHYDROGENASE IN MAMMALIAN NERVE BY IODOACETIC ACID , 1971, Journal of neurochemistry.

[22]  G I Bell,et al.  Structure and function of mammalian facilitative sugar transporters. , 1993, The Journal of biological chemistry.

[23]  E. Hirsch,et al.  Dopaminergic and cholinergic lesions in progressive supranuclear palsy , 1985, Annals of neurology.

[24]  Y. Agid,et al.  Rescue of Mesencephalic Dopamine Neurons by Anticancer Drug Cytosine Arabinoside , 1997, Journal of neurochemistry.

[25]  J. Barrett,et al.  Cryopreservation of primary neurons for tissue culture , 1986, Brain Research.

[26]  M. Fillenz,et al.  Extracellular Brain Glucose Levels Reflect Local Neuronal Activity: A Microdialysis Study in Awake, Freely Moving Rats , 1992, Journal of neurochemistry.

[27]  D. Brooks,et al.  Atypical parkinsonism in Afro‐Caribbean and Indian origin immigrants to the UK , 2000, Movement disorders : official journal of the Movement Disorder Society.

[28]  H. Miyoshi,et al.  Essential structural factors of acetogenins, potent inhibitors of mitochondrial complex I. , 2002, Bioorganic & medicinal chemistry letters.

[29]  J. Dartigues,et al.  Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[30]  A. Godoy,et al.  Expression of the hexose transporters GLUT1 and GLUT2 during the early development of the human brain , 1999, Brain Research.

[31]  D. Choi Ionic dependence of glutamate neurotoxicity , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  H. Freeze,et al.  Studies of mannose metabolism and effects of long-term mannose ingestion in the mouse. , 2001, Biochimica et biophysica acta.

[33]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[34]  L. Golbe,et al.  Prevalence and natural history of progressive supranuclear palsy , 1988, Neurology.

[35]  L. Netchiporouk,et al.  Brain extracellular glucose assessed by voltammetry throughout the rat sleep–wake cycle , 2001, The European journal of neuroscience.

[36]  M. Vila,et al.  Free radical and nitric oxide toxicity in Parkinson's disease. , 2003, Advances in neurology.

[37]  Samuel M. Goldman,et al.  EPIDEMIOLOGY OF PARKINSON'S DISEASE , 1996, Neurologic Clinics.

[38]  H. Shimada,et al.  The localisations in liposomal membranes of the tetrahydrofuran ring moieties of the annonaceous acetogenins, annonacin and sylvaticin, as determined by 1H NMR spectroscopy. , 1998, Pharmacological research.

[39]  A. Benabid,et al.  Unlike MPP+, apoptosis induced by 6-OHDA in PC12 cells is independent of mitochondrial inhibition , 1996, Neuroscience Letters.

[40]  K. Lange Role of microvillar cell surfaces in the regulation of glucose uptake and organization of energy metabolism. , 2002, American journal of physiology. Cell physiology.

[41]  Y. Agid,et al.  Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy , 1995, Neurology.

[42]  S. Snyder,et al.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Ruberg,et al.  Noradrenaline provides long‐term protection to dopaminergic neurons by reducing oxidative stress , 2001, Journal of neurochemistry.

[44]  M. Ruberg,et al.  Survival promotion of mesencephalic dopaminergic neurons by depolarizing concentrations of K+ requires concurrent inactivation of NMDA or AMPA/kainate receptors , 2001, Journal of neurochemistry.

[45]  M. Ruberg,et al.  Activation of the mitogen-activated protein kinase (ERK(1/2)) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons. , 2002, Molecular pharmacology.